Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.
Fiche publication
Date publication
avril 2020
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
Tous les auteurs :
Laurent-Badr Q, Barbe C, Brugel M, Hautefeuille V, Volet J, Grelet S, Desot E, Botsen D, Deguelte S, Pitta A, Abdelli N, Brasseur M, De Mestier L, Neuzillet C, Bouché O
Lien Pubmed
Résumé
The effect of treatment delay on survival in pancreatic ductal adenocarcinoma (PDAC) remains unclear.
Mots clés
Chemotherapy, Pancreatic cancer, Survival, Time intervals, Time to diagnosis, Time to treatment
Référence
Dig Liver Dis. 2020 Apr 30;: